PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCER

May 1, 2011, 00:00
10.1016/j.jval.2011.02.916
https://www.valueinhealthjournal.com/article/S1098-3015(11)01055-2/fulltext
Title : PCN61 COST-EFFECTIVENESS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY FOR EARLY STAGE OF HER2-POSITIVE BREAST CANCER
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01055-2&doi=10.1016/j.jval.2011.02.916
First page : A165
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 389
Categories :
Tags :
Regions :
ViH Article Tags :